HLS TherapeuticsTSX:HLS -2.82%62 Days Inventory is 264.58 as of Mar. 2026, which is 28% below its 10-year median of 365.85. GuruFocus rates TSX:HLS with a GF Score™ of 62/100 and a GF Value™ of C$4.47 (Fairly Valued). The stock has 4 warning signs investors should review. Among 916 Drug Manufacturers companies, HLS Therapeutics ranks worse than 77.95% on this metric.
The historical rank and industry rank for HLS Therapeutics's Days Inventory or its related term are showing as below:
TSX:HLS'
s Days Inventory Range Over the Past 10 Years
Min: 119.5 Med: 365.85 Max: 898.68
Current: 262.27
During the past 13 years, HLS Therapeutics's highest Days Inventory was 898.68. The lowest was 119.50. And the median was 365.85.
TSX:HLS's Days Inventory is ranked worse than 77.95% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs TSX:HLS: 262.27
HLS Therapeutics's Days Inventory
declined
from Mar. 2025 (313.37) to Mar. 2026 (264.58).
Inventory Turnover measures how fast the company turns over its inventory within a year.
HLS Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.34.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
HLS Therapeutics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.60.
HLS Therapeutics (TSX:HLS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
HLS Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
HLS Therapeutics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
HLS Therapeutics Days Inventory Related Terms
HLS Therapeutics Days Inventory Historical Data
* Premium members only.
The historical data trend for HLS Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, HLS Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HLS Therapeutics Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, HLS Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where HLS Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HLS Therapeutics (TSX:HLS) has a Days Inventory of 264.58 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on HLS Therapeutics and its competitors. This is 28% below median its historical median of 365.85. Over the past decade, HLS Therapeutics' Days Inventory has ranged from 119.50 to 898.68. According to the industry distribution chart, HLS Therapeutics ranks #714 out of 916 companies in the Drug Manufacturers industry, placing it in the top 77.9%.
Is HLS Therapeutics' Days Inventory too high?
HLS Therapeutics' current Days Inventory of 264.58 is 28% below median its 10-year median of 365.85. Over the past 10 years, this metric has ranged from a low of 119.50 to a high of 898.68. The Drug Manufacturers industry median Days Inventory is 164.43. HLS Therapeutics' value of 264.58 is 60.9% above this industry median. Based on the distribution chart, HLS Therapeutics ranks #714 out of 916 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, HLS Therapeutics has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HLS Therapeutics' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, HLS Therapeutics ranks #714 out of 916 companies for Days Inventory. This places HLS Therapeutics in the lower half of its industry. The industry median Days Inventory is 164.43. HLS Therapeutics' value of 264.58 is 60.9% above this benchmark. Historically, HLS Therapeutics' own Days Inventory has ranged from 119.50 to 898.68 over the past decade. While the company's 10-year median is 365.85 vs. the industry median of 164.43, HLS Therapeutics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HLS Therapeutics's current Days Inventory of 264.58 is 60.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on HLS Therapeutics and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HLS Therapeutics's current Days Inventory is 264.58, which is 28% below median its own 10-year median of 365.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HLS Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, HLS Therapeutics (TSX:HLS) is currently considered Fairly Valued. The stock's GF Value™ is C$4.47, compared to a current price of C$4.14 — trading 7.4% below its estimated fair value. The current Days Inventory is 264.58, which is 28% below median its 10-year median of 365.85 and 60.9% above the Drug Manufacturers industry median of 164.43. HLS Therapeutics' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For HLS Therapeutics (TSX:HLS), the current Days Inventory is 264.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HLS Therapeutics (TSX:HLS) Overvalued in 2026?
Based on GuruFocus' analysis, HLS Therapeutics stock appears to be undervalued.
The current stock price of C$4.14 is trading 7.4% below its estimated GF Value™ of C$4.47.
GuruFocus considers HLS Therapeutics to be Fairly Valued.
Key valuation signals for TSX:HLS:
Days Inventory: 264.58 (28% below median its 10-year median of 365.85)
GF Value™: C$4.47 vs. price of C$4.14 (7.4% below fair value)
Industry Position: 60.9% above the Drug Manufacturers median (#714 of 916)
No single metric tells the full story. See the TSX:HLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company's products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of world, with the majority of its revenue generated from Canada.
62GF Score
Get the complete analysis for TSX:HLS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:HLS has been successfully added to your 
